CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
tDCSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02128919
NCT02128919N/ACompleted

Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic

Nathan Kline Institute for Psychiatric Research·interventional·Posted May 1, 2014·Updated Aug 30, 2017

In Brief

A clinical study evaluating tDCS for Schizophrenia and 2 related conditions. Completed, enrolled 33 participants across 1 site.

Detailed Summary

This is a study of the effects of tDCS on smoking, craving for cigarettes, cognition, and psychiatric symptoms in schizophrenic patients who are current smokers or have a history of regular cigarette smoking. It assesses smoking with CO monitoring, nicotine and nicotine levels, and craving with QSU scale and response to craving slides. Cognition is measured by MCCB, symptoms are measured by PANSS and hallucination scale. This is a double-blind sham-controlled study with active tDCS 2ma or 20 minutes over 5 days, and sham tDCS for 40 seconds on each sham occasion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 1, 2014
Enrollment StartApr 1, 2012
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 12.2 years ago

Interventions

tDCSdevice

Transcranial Direct Current Stimulation